Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P1283: ANTI-CD19 CHIMERIC ANTI...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD

P1283: ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY FOLLOWED BY UMBILICAL CORD BLOOD TRANSPLANTATION IN PEDIATRIC RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: GOOD SURVIVAL AND LESS GVHD

Bibliographic Details
Main Author: Fang Liu
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000972020.41459.e6
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000972020.41459.e6

Similar Items

  • Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    by: Guoqing Wei, et al.
    Published: (2017-04-01)
  • CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
    by: Qianwen Xu, et al.
    Published: (2022-01-01)
  • Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    by: Franco Locatelli, et al.
    Published: (2024-05-01)
  • Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia
    by: Ibrahim Aldoss, et al.
    Published: (2023-07-01)
  • Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
    by: Xiangyu Zhao, et al.
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs